Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

286.74 

-1.90 -0.7%

as of Aug 20 '19

52 Week Range:

268.68 380.76


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a partnership with Lundbeck Foundation GeoGenetics Centre for exploring the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens; and an agreement with HTG Molecular Diagnostics, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Equity (BVPS) 8.53
10.64
10.76
8.87
13.23
15.25
19.42
23.83
growth rate 24.7% 1.1% -17.6% 49.2% 7.4% 12.9% 22.7%
Earnings BIT 185.38
222.61
159.31
492.17
626.00
578.00
629.00
883.00
growth rate 9.6% -28.4% 208.9% 12.8% -3.9% 8.8% 40.4%
Avg.PE 72.99
49.02
123.46
85.71
51.16
53.21
44.80
50.87
growth rate -18.1% 151.9% -30.6% -22.7% 2.0% -15.8% 13.6%
ROA 4.29
6.35
4.49
11.11
13.14
11.40
15.20
13.52
growth rate 48.0% -29.3% 147.4% 18.3% -6.9% 15.5% -11.1%
ROE 7.62
12.64
8.79
23.59
27.88
22.45
29.32
25.39
growth rate 65.9% -30.5% 168.4% 18.2% -10.3% 14.3% -13.4%
ROIC 5.39
8.13
6.69
14.86
17.24
14.73
19.50
17.02
growth rate 50.8% -17.7% 122.1% 16.0% -7.6% 15.1% -12.7%
Cur. Ratio 6.50
5.87
5.02
2.62
3.43
3.29
3.99
2.49
growth rate -9.7% -14.5% -47.8% 30.9% -2.1% 10.1% -37.6%
Quick Ratio 5.74
5.14
4.36
2.25
2.90
2.75
3.43
2.23
growth rate -10.5% -15.2% -48.4% 28.9% -2.6% 11.7% -35.0%
Leverage 2.04
1.95
1.97
2.28
1.99
1.95
1.91
1.85
growth rate -4.4% 1.0% 15.7% -12.7% -1.0% -1.0% -3.1%
Balance Sheet Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Acct.Receivable 165.60
245.43
275.02
289.46
385.53
381.00
411.00
514.00
growth rate 21.7% 12.1% 5.3% 15.4% -0.6% 7.9% 25.1%
Acct.Payable 267.60
292.78
82.63
139.23
138.00
160.00
184.00
growth rate 9.4% -71.8% 29.8% -0.4% 15.9% 15.0%
Cur.Assets 1,258.40
1,787.05
1,617.54
1,889.60
2,096.82
2,318.00
2,980.00
4,490.00
growth rate 19.2% -9.5% 16.8% 5.3% 5.1% 28.6% 50.7%
Total Assets 1,839.10
2,566.09
3,019.01
3,339.64
3,687.75
4,281.00
5,257.00
6,959.00
growth rate 18.1% 17.7% 10.6% 5.1% 7.7% 22.8% 32.4%
Cash 248.90
433.98
711.64
636.15
768.77
735.00
1,225.00
1,144.00
growth rate 32.1% 64.0% -10.6% 9.9% -2.2% 66.7% -6.6%
Inventory 142.20
158.72
154.10
191.14
270.78
300.00
333.00
386.00
growth rate 5.7% -2.9% 24.0% 19.0% 5.3% 11.0% 15.9%
Cur.Liabilities 534.50
304.57
322.06
722.16
610.49
705.00
746.00
1,804.00
growth rate -24.5% 5.7% 124.2% -8.1% 7.5% 5.8% 141.8%
Liabilities 641.40
1,247.50
1,485.80
1,876.84
1,806.65
1,967.00
2,288.00
3,053.00
growth rate 39.5% 19.1% 26.3% -1.9% 4.3% 16.3% 33.4%
LT Debt 0.00
805.41
839.31
986.78
1,015.65
1,056.00
1,182.00
890.00
growth rate 4.2% 17.6% 1.5% 2.0% 11.9% -24.7%
Equity 1,197.70
1,318.58
1,533.20
1,462.80
1,848.55
2,197.00
2,749.00
3,758.00
growth rate 4.9% 16.3% -4.6% 12.4% 9.0% 25.1% 36.7%
Common Shares 139.00
134.00
140.00
149.00
149.00
2.00
2.00
2.00
2.00
growth rate -3.6% 4.5% 6.4% 0.0% -88.4% 0.0% 0.0% 0.0%
Cash Flow Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Capital Expenditures 49.80
68.78
79.22
106.00
143.00
260.00
310.00
296.00
growth rate 17.5% 15.2% 33.8% 16.2% 34.8% 19.2% -4.5%
Cash Dividends 0.00 0.00
growth rate
Cash From OA 272.60
291.87
386.42
501.27
786.00
779.00
875.00
1,142.00
growth rate 3.5% 32.4% 29.7% 25.2% -0.5% 12.3% 30.5%
FCF per Share 1.83
1.58
1.93
2.53
2.60
2.85
2.92
5.60
growth rate -13.7% 22.2% 31.1% 2.8% 4.7% 1.2% 91.8%
Sale Purchase of Stock -28.16
-80.56
96.33
72.00
47.00
71.00
growth rate 0.0% 100.0% -13.6% -19.2% 51.1%
FCF 222.80
279.00
211.00
296.00
359.00
516.00
643.00
416.00
519.00
563.00
846.00
growth rate 25.2% -24.4% 40.3% 21.3% 43.7% 24.6% -35.3% 24.8% 8.5% 50.3%
Income Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Sales 902.70
1,148.52
1,421.18
1,861.36
2,220.00
2,398.00
2,752.00
3,333.00
growth rate 12.8% 23.7% 31.0% 9.2% 3.9% 14.8% 21.1%
Op.Income 211.70
151.25
125.31
492.17
626.00
578.00
629.00
883.00
growth rate -15.5% -17.2% 292.8% 12.8% -3.9% 8.8% 40.4%
IBT 185.40
222.61
159.31
448.76
583.00
561.00
1,043.00
894.00
growth rate 9.6% -28.4% 181.7% 14.0% -1.9% 85.9% -14.3%
Net Income 124.90
151.25
125.31
353.35
462.00
463.00
726.00
826.00
growth rate 10.1% -17.2% 182.0% 14.4% 0.1% 56.8% 13.8%
EPS 0.62
1.13
0.90
2.37
3.10
3.07
4.92
5.56
growth rate 82.3% -20.4% 163.3% 30.8% -0.5% 26.6% 13.0%
Gross Profit 601.50
773.53
911.89
1,337.08
1,595.00
1,709.00
1,883.00
2,335.00
growth rate 13.4% 17.9% 46.6% 9.2% 3.5% 10.2% 24.0%
R&D 177.90
231.03
276.74
306.06
362.00
458.00
495.00
568.00
growth rate 14.0% 19.8% 10.6% 8.8% 12.5% 8.1% 14.8%

Quarterly Statements

Item Name Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Earnings BIT 218.00
241.00
197.00
204.00
205.00
growth rate 10.6% -18.3% 3.6% 0.5%
Balance Sheet Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 400.00
433.00
514.00
457.00
470.00
growth rate 8.3% 18.7% -11.1% 2.8%
Acct.Payable 151.00
156.00
184.00
137.00
139.00
growth rate 3.3% 18.0% -25.5% 1.5%
Cur.Assets 3,194.00
4,262.00
4,490.00
4,545.00
4,156.00
growth rate 33.4% 5.4% 1.2% -8.6%
Total Assets 5,542.00
6,759.00
6,959.00
7,390.00
6,973.00
growth rate 22.0% 3.0% 6.2% -5.6%
Cash 1,560.00
1,346.00
1,144.00
2,270.00
1,943.00
growth rate -13.7% -15.0% 98.4% -14.4%
Inventory 350.00
374.00
386.00
412.00
420.00
growth rate 6.9% 3.2% 6.7% 1.9%
Cur.Liabilities 1,180.00
1,735.00
1,804.00
1,241.00
612.00
growth rate 47.0% 4.0% -31.2% -50.7%
Liabilities 2,254.00
2,947.00
3,053.00
3,283.00
2,641.00
growth rate 30.8% 3.6% 7.5% -19.6%
LT Debt 710.00
860.00
890.00
1,112.00
1,120.00
growth rate 21.1% 3.5% 24.9% 0.7%
Equity 3,008.00
3,503.00
3,758.00
3,985.00
4,332.00
growth rate 16.5% 7.3% 6.0% 8.7%
Common Shares 2.00
2.00
2.00
2.00
2.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 90.00
64.00
65.00
56.00
47.00
growth rate -28.9% 1.6% -13.9% -16.1%
Cash Dividends
growth rate
Cash From OA 255.00
292.00
300.00
198.00
143.00
growth rate 14.5% 2.7% -34.0% -27.8%
Sale Purchase of Stock 21.00
1.00
growth rate -95.2%
FCF 165.00
228.00
235.00
142.00
96.00
growth rate 38.2% 3.1% -39.6% -32.4%
Income Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Sales 782.00
853.00
867.00
846.00
838.00
growth rate 9.1% 1.6% -2.4% -1.0%
Op.Income 218.00
241.00
197.00
204.00
205.00
growth rate 10.6% -18.3% 3.6% 0.5%
IBT 221.00
232.00
209.00
233.00
346.00
growth rate 5.0% -9.9% 11.5% 48.5%
Net Income 208.00
199.00
210.00
233.00
296.00
growth rate -4.3% 5.5% 11.0% 27.0%
EPS
growth rate
Gross Profit 546.00
607.00
599.00
593.00
583.00
growth rate 11.2% -1.3% -1.0% -1.7%
R&D 137.00
159.00
121.00
169.00
166.00
growth rate 16.1% -23.9% 39.7% -1.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (96.17)

YOY Growth Grade:

B (74.34)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 56.91 50.13 42.50
EPS / Growth 20.5% 5.72 14.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 24.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 14.2% 19.6% 19.6%
Future PE 28.44 46.20 46.20
Future EPS 21.62 34.23 34.23
Value Price
MOS %
151.97
-47.0%
390.81
36.3%
390.81
36.3%
MOS Price 75.99 195.40 195.40
IRT 14.88 12.39 12.39

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.